Credores da Braskem rejeitam proposta e BRKM5 fica a 4 dias da recuperação judicial: o que acontece com o acionista Relevância10,0
URGENTE

Braskem Debt Rejection: What Happens to BRKM5 Shares After This Setback?

Creditors have rejected Braskem's latest restructuring proposal, bringing the petrochemical giant closer to Chapter 11-style bankruptcy protection as the November 22 deadline approaches.

Braskem creditors have rejected the company's latest debt restructuring proposal, according to people familiar with the matter cited by Bloomberg. With the November 22 deadline just days away—the cutoff separating an out-of-court agreement from court-supervised bankruptcy protection—the message for shareholders is clear: any path forward from here is likely to come at a higher cost to equity investors.

What Happened to Braskem?

According to Bloomberg, creditors holding Braskem (BRKM5) shares rejected the company's latest proposal to restructure its debts, leaving the parties with only days to reach an agreement and avoid a formal bankruptcy filing. The rejected offer included a $1.1 billion equity injection from shareholders and the conversion of $2.9 billion in debt into equity, meaning creditors would swap a portion of what they are owed for shares. Sources spoke on condition of anonymity. The company has not confirmed the rejection, stating that it maintains regular communication with the market and that updates will be disclosed through official channels.

The proposal also included a conditional component: an additional $300 million in equity contributions and the conversion of $900 million in debt, if necessary to meet specific targets, raising the potential totals to $1.4 billion and $3.8 billion, respectively. The reaction was swift on the New York Stock Exchange, where Braskem trades ADRs (American Depositary Receipts): according to Bloomberg, the stock tumbled 14% on Monday. Meanwhile, movement is already underway on the other side of the table as some creditors work on a counterproposal.

Why was the offer turned down given the substantial headline figures? The answer lies in how it compares to previous rounds.

Why Did Creditors View the Offer as a Step Backward?

Compared to the October terms, the new offer puts less money from the controlling owners on the table and places a heavier burden on creditors. According to Bloomberg, the terms were seen as a retreat from the proposal the company made public in October. The table outlines the four known rounds of negotiation:

RoundShareholder ContributionDebt Converted into SharesOutcome
Creditor Demand (Sept/26)~US$ 3.5 billionNot disclosedRejected by shareholders
Braskem, Oct/26 (Public)US$ 1.2 billion + up to US$ 500 millionUp to US$ 2.8 billion + US$ 500 million to $1 billion in June 2029Deemed insufficient
New York Meeting (Early Nov)Up to US$ 1.4 billionUS$ 3.8 billionRejected
Latest Offer (Nov/26)US$ 1.1 billion + US$ 300 millionUS$ 2.9 billion + US$ 900 millionRejected

Adding the components together, the October proposal reached up to $1.7 billion in fresh capital (our calculation). The latest offer stops at $1.4 billion, featuring $100 million less in guaranteed capital injections and $100 million more in guaranteed debt conversion. The maximum caps match those from the round that stalled earlier this month in New York. In other words, the company returned with the same overall math, simply redistributed. Prior to this, Petrobras reduced its capital contribution from $1.7 billion to $1.4 billion, according to reporting by InfoMoney. A wide gap remains: in September, creditors advocated for approximately $3.5 billion in new capital commitments from major shareholders, including Petrobras and IG4.

We covered this tug-of-war during the October negotiation round. The new development is that the clock has nearly run out.

What Happens If There Is No Agreement by November 22?

Braskem would be forced to file for judicial reorganization. The company filed for an out-of-court restructuring process on August 24 with initial backing from creditors representing 39.6% of covered debt, and it requires majority support to advance the extrajudicial plan. The process covers approximately $10.9 billion in unsecured debt, and the 90-day statutory stay period concludes on November 22. Because that date falls on a Sunday, Folhapress points to November 23 as the effective operational window. A one-day difference does not alter the pressure. Along the way, interim milestones were pushed back repeatedly: a November 6 deadline expired after three extensions, followed by another extension to November 12.

On-Time AgreementOut-of-Court

The creditors' counterproposal meets shareholders halfway. The company avoids formal bankruptcy protection, but the likely price includes more debt converted into equity and greater dilution.

More TimeUncertain

The parties have extended negotiation milestones before. It remains unclear whether the legal framework permits another extension.

No AgreementJudicial Reorganization

A longer, more costly process that can encompass all creditors. In restructurings, equity holders sit at the bottom of the capital structure.

A favorable scenario for the company is not necessarily favorable for equity investors. That is the reality already reflected in the stock price.

How Much Could This Cost BRKM5 Shareholders?

The central risk is dilution. By converting debt into shares, each creditor becomes a partner, shrinking the equity stake of existing shareholders. The conversion price was not disclosed, but the scale of the challenge is measurable. Braskem has approximately 797 million shares outstanding (common and preferred combined). With the stock trading near R$ 3, where Status Invest and Investidor10 placed the shares this week, the company's market capitalization stands at roughly R$ 2.4 billion. At an implied exchange rate of about R$ 5.50 per dollar, that equates to roughly $0.44 billion (our estimate). The guaranteed portion of the latest offer alone—$4 billion between capital injections and converted debt—amounts to approximately nine times the company's current market value. Even with a conversion premium, investors who do not participate in a capital increase are likely to be left with a small fraction of the company.

The decline has already been severe. According to Investidor10, the stock started the year trading around R$ 7.89, representing a loss of nearly two-thirds in 2026. The company's cash position offers no relief, as we detailed in our coverage of the billion-reais third-quarter loss. Furthermore, dividends are not a factor: the last payment, according to Status Invest, occurred in May 2022.

What This Means for Shareholders

The rejection is not the end of the road, but it clarifies who pays the bill: creditors want more cash from Petrobras and IG4 and less debt turned into stock. If creditors prevail, dilution is lower, but it requires a cash commitment that controlling shareholders have continually scaled back. If creditors lose or no agreement is reached, the stock remains exposed to formal bankruptcy proceedings. Under any outcome, minority shareholders have no seat at the negotiation table and should expect extreme volatility as the deadline approaches.

Questions Shareholders Are Asking Now

Can Braskem go bankrupt? Judicial reorganization is not liquidation: it is a legal process where a company seeks court protection to renegotiate with all creditors simultaneously. The risk for shareholders lies in the resulting restructuring plan, which typically imposes heavy dilution. The mechanism is explained in our analysis of the debt that triggered the out-of-court filing.

Why isn't Petrobras putting up more money? Sources did not provide specific reasons. What is known is that creditors want the state-controlled oil giant to contribute more cash and convert less of its own debt into shares, while the proposed capital injection has shrunk with each successive round. That is the core deadlock in the negotiation.

Have there been any periods of relief? Yes. Last week, expectations ran high for finalizing the out-of-court agreement on a Wednesday, which ultimately did not happen. Reports of an imminent agreement come and go. Only official regulatory filings matter.

  • Credores negociando: According to Bloomberg, two groups have already presented proposals and a counterproposal is in preparation.
  • A distância caiu desde setembro: The gap has narrowed since September, down from a demand of roughly $3.5 billion compared to the $1.4 billion currently offered.
  • A oferta da empresa encolheu em relação a outubro: The company's offer shrank relative to October, signaling that controlling shareholders are resisting additional capital commitments.
  • A adesão formal segue nos 39,6%: Formal backing remains at 39.6% of the initial filing, far short of the required majority as the deadline virtually expires.
  • Com um pacote de cerca de nove vezes o valor de mercado: With a restructuring package valued at roughly nine times the company's market cap, dilution weighs heavily on minority investors in any negotiated outcome.